Report ID : 1376341 | Published : June 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Virology Test Market is categorized based on Test Type (PCR Tests, Antigen Tests, Serology Tests, Viral Culture Tests, Next-Generation Sequencing) and Application (Clinical Diagnostics, Research, Blood Screening, Transplantation, Veterinary Diagnostics) and End User (Hospitals, Diagnostic Laboratories, Academic & Research Institutions, Blood Banks, Pharmaceutical Companies) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The Virology Test Market size was valued at USD 5.5 billion in 2023 and is projected to reach USD 10.2 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033. This report includes various market segments and analyzes the key trends and factors influencing market growth.
Growth in the Virology Test Market is related to the viral infection rate along with the need for competent diagnostic measures. During pandemics or widespread outbreaks, healthcare systems globally focus on improving their surveillance systems and managing diseases. Along with this focus, healthcare systems now consider virology testing as an essential part of public health and epidemiology to control and prevent infectious diseases, and this surge in demand has opened up new markets due to advances in public health.
In addition to this, the testing world is dynamically changing due to contact fractures demanding more efficient and sequential tests. Governments and health bodies pouring funds into R&D is proving beneficial as there has been a boom in novel assays and molecular diagnostics tools. This paradigm shift not only enables ease and convenience in diagnostic testing but strengthens comprehensive cancer care through targeted therapy. In the context of the Virology Test Market, one lesson that can be learned is to adapt quickly to the innovative technologies for public health to harness the full potential of advancement.
ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2023-2033 |
BASE YEAR | 2023 |
FORECAST PERIOD | 2024-2033 |
HISTORICAL PERIOD | 2023-2024 |
UNIT | VALUE (USD BILLION) |
KEY COMPANIES PROFILED | Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), Qiagen, bioMerieux SA, Cepheid, Hologic Inc., PerkinElmer Inc., Luminex Corporation, Siemens Healthineers |
SEGMENTS COVERED |
By Test Type - PCR Tests, Antigen Tests, Serology Tests, Viral Culture Tests, Next-Generation Sequencing By Application - Clinical Diagnostics, Research, Blood Screening, Transplantation, Veterinary Diagnostics By End User - Hospitals, Diagnostic Laboratories, Academic & Research Institutions, Blood Banks, Pharmaceutical Companies By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
The Virology Test Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
Verified Industry Insights offers one of the following report customization options to our respectable clients :
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved